Area of research
Psychiatry and Mental health · Pharmacology
Research interest
Research interests include Schizophrenia research and treatment, Treatment of Major Depression, Electroconvulsive Therapy Studies, and Pharmacological Effects and Toxicity Studies.
Lumateperone for the Treatment of Major Depressive Disorder With Mixed Features or Bipolar Depression With Mixed Features
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants
Expert consensus statement for telepsychiatry and attention-deficit hyperactivity disorder
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
Esmethadone-HCl (REL-1017): a promising rapid antidepressant
Adjunctive agents to antipsychotics in schizophrenia: a systematic umbrella review and recommendations for amino acids, hormonal therapies and anti-inflammatory drugs
Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations
Trazodone once-a-day: A formula for addressing challenges in antidepressant safety and tolerability
Muscarinic acetylcholine receptors for psychotic disorders: bench-side to clinic
The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression
Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors
Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling
The effect of first- and second-generation antipsychotics on brain morphology in schizophrenia: A systematic review of longitudinal magnetic resonance studies with a randomized allocation to treatment arms
Neuropsychiatric Consequences of COVID-19 Pandemic: A Synthetic Review from a Global Perspective.
Stahl's Essential Psychopharmacology
REL-1017 (Esmethadone) Increases Circulating BDNF Levels in Healthy Subjects of a Phase 1 Clinical Study
How and when to treat the most common adverse effects of antipsychotics: Expert review from research to clinical practice.
Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data
Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies
Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity
Expert Consensus on Screening and Assessment of Cognition in Psychiatry
Guidelines for the recognition and management of mixed depression
The pharmacodynamic effects of combined administration of flibanserin and alcohol
Hypoactive Sexual Desire Disorder
A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature
Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability
Modulating the serotonin system in the treatment of major depressive disorder
A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria